Review article: Helicobacter species and in vivo models of gastrointestinal cancer

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue SUPPL. 1, 1998, Pages 37-60

  Fox, J G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARCINOGEN;

ANIMAL MODEL; CHEMICAL CARCINOGENESIS; CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; DOG; DRUG METABOLISM; EXPERIMENTAL ANIMAL; FERRET; HAMSTER; HELICOBACTER; HELICOBACTER PYLORI; HUMAN; LIVER CANCER; MOUSE; NONHUMAN; NUTRITION; PRIMATE; PRIORITY JOURNAL; RAT; RODENT; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH DISEASE;

ADENOCARCINOMA; ANIMALS; DIET; DISEASE MODELS, ANIMAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS;

EID: 0031950780     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1998.00008.x     Document Type: Review

References (207)

1. Rotterdam H, Enterline N T. Pathology of the Stomach and Duodenum. Springer-Verlag, New York, 1989.
2. Davis G R. Neoplasms of the stomach. In: Sleisenger M, Fordtran JS eds. Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 4th edn. W B Saunders, Philadelphia, 1989, pp. 745-72.
3. Sipponen P. Helicobacter pylori infection: a common worldwide environmental risk factor for gastric cancer? Endoscopy 1992; 24: 424-7.
4. Sipponen P, Siurala M, Goodwin C S. Histology and ultrastructure of Helicobacter pylori infections: gastritis, duodenitis and peptic ulceration and their relevance as precancerous conditions. In: Goodwin CS, Worsley BW eds. Helicobacter pylori: Biology and Clinical Practice. CRC Press, Boca Raton FL, 1993, pp. 37-62.
5. Koster T, Vandenbrouke J P. Helicobacter pylori: musings from the epidemiological armchair. Epidemiol Infect 1992; 109: 81-5.
6. Charnley G, Tannenbaum S R, Correa P. Gastric cancer: an etiologic model. In: Nitrosamines in Human Cancer, Magee PN, ed. Reprinted from Branbury Report 12: Cold Spring Harbour Laboratories, New York, 1982, pp. 503-22.
7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-40.
8. Correa P. Mechanisms of gastric carcinogenesis. In: Joossens JV, Hill MJ, Geboers J eds. Diet and Human Carcinogenesis. Elsevier, Amsterdam, 1985, pp. 109-15.
9. Correa P. Carcinoma of the stomach. Proc Nutr Soc 1985; 44: 111-12.
10. Charnley G, Tannenbaum S R. Flow cytometric analysis of the effect of sodium chloride on gastric cancer risk in the rat. Cancer Res 1985; 45: 5608-16.
11. Balansky R M, Blagoeva P M, Mircheva Z I, et al. The effect of antioxidants on MNNG-induced stomach carcinogenesis in rats. J Cancer Res Clin Oncol 1986; 112: 272-5.
12. Fox J G, Correa P, Taylor N S, et al. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population at increased risk of gastric cancer. Am J Gastroenterol 1992; 87: 1554-60.
13. Mitchell H M. The epidemiology of Helicobacter pylori infection and its relation to gastric cancer. In: Goodwin CS, Worsley BW eds. Helicobacter pylori: biology and clinical practice. CRC Press, Boca Raton, FL, 1993, pp. 95-114.
14. Parsonnet J, Friedman G D, Vandersteen D P, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
15. Nomura A, Stemmerman G N, Chyou P H, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Eng J Med 1991; 325: 113 2-6.
16. Talley N J, Kost L, Haddad A, et al. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol 1992; 30: 3146-50.
17. Forman D, Newell D G, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302: 1302-5.
18. IARC. Schistosomes, liver flukes, and Helicobacter pylori, In: IARC Monograph on the evaluation of carcinogenic risks to humans, vol. 61. Lyon, France, 1994.
19. Barker I K, Dreumel A A V. The alimentary system. In: Jubb KVFKP, Palmer N eds. Pathology of domestic animals, vol. 2. Academic Press, New York, 1985, pp. 1-237.
20. Jones T C, Hunt R D. Veterinary Pathology. Lea & Febiger, Philadelphia, 1983.
21. McClure H M, Chapman W L, Hooper B E, et al. The digestive system. In: Benirschke K, Garner F M, Jones TC eds. Pathology of Laboratory Animals, vol. 1. Springer-Verlag, New York, 1978, pp. 125-317.
22. Squire R A, Goodman D G, Valerio M G, et al. Tumors. In: Benirschke K, Garner FMJT eds. Pathology of Laboratory Animals, vol. 1. Springer-Verlag, New York, 1978, pp. 1051-283.
23. 3 McCarrison R. The pathogenesis of deficiency disease. On the occurrence of recently developed cancer of the stomach in a monkey fed on food deficient in vitamins. Indian J Med Res 1915; 7: 342-5.
24. Kimbrough R. Spontaneous malignant gastric tumor in a rhesus monkey (Macaca mulatta). Arch Pathol 1966; 81: 343-6.
25. Kent S P. Spontaneous and induced malignant neoplasms in monkeys. AnnNY AcadSci 1960; 85: 819-27.
26. O'Gara R W, Adamson R H. Spontaneous and induced neoplasms in nonhuman primates. In: Fiennes RL ed. Pathology of Simian Primates, Part I. Karger, Basel, 1972, pp. 190-238.
27. Ohgaki H, Hasegawa H, Kusama K. Squamous cell carcinoma found in the cardiac region of the stomach of an aged orangoutang. Gann 1984; 75: 415-7.
28. Ruch T C. Neoplasia. In: Ruch TC ed. Diseases of Laboratory Primates. Saunders, Philadelphia, 1959, pp. 529-67.
29. Newberne J W, Robinson V B. Spontaneous tumours in primates - a report of two cases with note on the apparent low incidence of neoplasms in subhuman primates. Am J Vet Res 1960; 21: 150-5.
30. Bonne C, Sandground J H. On the production of gastric tumors, bordering on malignancy in Javenese monkeys through the agency of Nochtia nochti, a parasitic nematoda. Am J Cancer 1939; 37: 173-85.
31. Lapin B A, Yakovleva L A. Tumors of gastrointestinal tract after long term cholesterol feeding. Arch Pathol 1959; 21: 25-31.
32. Fox J G, Dangler C A, Sager W, et al. Helicobacter mustelae associated gastric adenocarcinoma in ferrets (Mustela putorius furo). Vet Pathol 1997; 34: 225-9.
33. Stauber E, Kraft S, Roninette J, et al. Multiple tumors in a ferret. J Sm Exotic Anim Med 1991; 87-8.
34. Rice L E, Stahl S J, McLeod C G. Pyloric adenocarcinoma in a ferret. J Am Vet Med Assoc 1992; 200: 1117-8.
35. Sleeman J M, Clyde V L, Jones M P, et al. Two cases of pyloric adenocarcinoman in the ferrets (Mustela putorius furo). Vet Rec 1995; 17: 272-3.
36. Fox J G, Wishnok J S, Murphy J C, et al. MNNG-induced gastric carcinoma in ferrets infected with Helicobacter mustelae. Carcinogenesis 1993; 14: 1957-61.
37. Severenson R K. Increasing incidence of primary gastric lymphoma. Cancer 66: 1238-87.
38. Rubin E, Farber J L. The gastrointestinal tract. In: Rubin E, Farber JL eds. Essential Pathology. J B Lippincott, Philadelphia, 1990, pp. 352-92.
39. Parsonnet J, Hanson S, Rodriguez L, et al. Helicobacter pylori infection and gastric MALT lymphoma. N Engl J Med 1994; 330: 1267-71.
40. Genta R M, Hamner H W, Graham D Y. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol 1993; 24: 577-83.
41. Genta R M, Hamner H W. Significance of lymphoid follicles in the interpretation of gastric biopsy specimens. Arch Pathol Lab Med 1994; 118: 740-3.
42. Isaacson P G, Spencer J, Wright D H. Classifying primary gut lymphomas. Lancet 1988; ii: 1148-9.
43. Isaacson P G, Spencer J. The biology of low grade MALT lymphoma. J Clin Pathol 1995; 48: 395-7.
44. Isaacson P G, Wright D H. Malignant lymphoma of mucosa-associated lymphoid tissue. Cancer 1983; 52: 1410-16.
45. Wotherspoon A C, Doglioni C, Diss T C, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.
46. Erdman S E, Correa P, Li X, et al. Helicobacter mustelae-associated mucosa associated lymphoid tissue (MALT) lymphoma in ferrets. Am J Pathol 199 7; 151: 273-80.
47. Erdman S E, Brown S A, Kawasaki T A, et al. Clinical and pathological findings in lymphoma in ferrets: 60 cases (1985-1994). J Am Vet Med Assoc 1996; 208: 1285-9.
48. Savio A, Frazin G, Wotherspoon A C, et al. Diagnosis and post-treatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 1996; 87: 1255-60.
49. Bralow S P. Experimental gastric carcinogenesis. Digestion 1972; 5: 290-310.
50. Klein A J, Palmer W L. Experimental gastric carcinoma: a critical review with comments on the criteria of induced malignancy. J Natl Cancer Inst 1941; 1: 559-84.
51. Sugimura T, Kawachi T. Experimental stomach cancer. Methods Cancer Res 1973; 7: 245-308.
52. Kawase S, Ishikura H. Female-predominant occurrence of spontaneous gastric adenocarcinoma in cotton rats. Lab Animal Sci 1995; 45: 244-8.
53. Stewart H L, Hare W V. Variations in susceptibility of the fundic and pyloric portions of the glandular stomach of the rat to induction of neoplasia by 20-methylcholanthrene. Acta Un Int Cancer 1950; 7: 176-7.
54. Morris H P, Wagner B P, Ray F E, et al. Comparative study of cancer and other lesions of rats fed N,N′-2,7-fluorenylenebisacetamide or N-2-fluorenylacetamide. NCI Monogr 1961; 5: 1-53.
55. Sugimura T, Fujimura S. Tumor production in glandular stomach of rat by N-methyl-N′nitro-N-nitrosoguanidine. Nature 1967; 216: 943-4.
56. Ohgaki H, Tomihara I, Sato S, et al. Differential proliferative response of gastric mucosa during carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in susceptible ACI rats, resistant Buffalo rats, and their hybrid F1 cross. Cancer Res 1988; 48: 5275-9.
57. Sorbye H, Kvinnsland S, Svanes K. Penetration of N-methyl-N′-nitro-N-nitrosoguanidine to proliferative cells in gastric mucosa of rats is different in pylorus and fundus and depends on exposure time and solvent. Carcinogenesis 1993; 14: 887-92.
58. SaitoT, Inokuchi K, Takayama S, et al. Sequential morphological changes in N-methyl-N′-nitro-N-nitrosoguanidine carcinogenesis in the glandular stomach of rats. J Natl Can Inst 1970; 44: 769-83.
59. Tatematsu M, Furihata C, Katsuyama T, et al. Independent induction of intestinal metaplasia and gastric cancer in rats treated with N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Research 1983; 43: 1335-41.
60. Shirai T. Periodical observations of the glandular stomach in rat treated with N-methyl-N'-nitro-N-nitrosoguanidine. Nagoya Med J 1974; 19: 155-67.
61. Matsukura N, Kawachi T, Sasjima K, et al. Induction of intestinal metaplasia in the stomachs of rats by N-methyl-N′-nitro-N-nitrosoguanidine. J Natl Can Inst 1978; 61: 141-4.
62. Sumi Y, Miyakawa M. Comparative studies on the production of stomach tumors following the intubation of several doses of N-methyl-N'-nitro-N-nitrosoguanidine. Gann 1981; 72: 700-4.
63. Tatematsu M, Furihata C, Mera Y, et al. Immunohistochemical demonstration of induction of pyloric glands with low pepsinogen 1 (Pg 1) content in rat stomach by N-methyl-N′-nitro-N-nitrosoguanidine. Jpn J Cancer Res 1986; 77: 238-43.
64. Tatematsu M, Furihata C, Katsuyama T, et al. Immunohistochemical demonstration of pyloric gland-type cells with low tissues of rat stomachs treated with N-methyl-N′-nitro-N-nitrosoguanidine. J Natl Cancer Inst 1987; 78: 771-7.
65. Tatematsu M, Aoki T, Asamoto M, et al. Enhancing effects of N-methyl-N'-nitro-N-nitrosoguanidine and sodium taurocholate on development of pepsinogen 1 decreased pyloric glands in rats initiated with N-methyl-N'-nitro-N-nitro-soguanidine. Jpn J Cancer Res 1987; 78: 312-6.
66. 6 Tatematsu M, Aoki T, Inoue T, et al. Coefficient of induction of pepsinogen 1-decreased pyloric glands and gastric cancers in five different strains of rats treated with N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis 1988; 9: 495-8.
67. Furihata C, Sasajima K, Kazama S, et al. Changes in pepsinogen isozymes in stomach carcinogenesis induced in rats by N-methyl-N′-nitro-N-nitrosoguanidine. J Natl Cancer Inst 1975; 55: 925-30.
68. Tatematsu M, Furihata C, Hirose M, et al. Changes in pepsinogen isozymes in stomach cancer induced in Wistar rats by N-methyl-N'-nitro-N-nitrosoguanidine and transplantable gastric carcinoma (SG2B). J Natl Cancer Inst 1977; 48: 1709-16.
69. Kodama M, Kodama T, Fukami H, et al. Genetics of host response to N-methyl-N′-nitro-N-nitrosoguanidine. I: Lack of tumor production in the glandular stomach of Swiss mouse. Anticancer Res 1992; 12: 441-50.
70. Sigaran M F, Con-Wong R. Production of proliferative lesions in gastric mucosa of albino mice by oral administration of N-methyl-N′-nitro-N-nitrosoguanidine. Gann 1979; 70: 343-52.
71. IARC. N-nitroso-N-methylurea. IARC Monographs on the evaluation of carcinogenic risk of chemicals to man. Lyon, 1977, pp. 227-55.
72. Tatematsu M, Ogawa K, Hishiva T, et al. Induction of adenocarcinomas in the glandular stomach of BALB/c mice treated with N-methyl-N-nitrosourea. Jpn J Cancer Res 1992; 83: 915-18.
73. Tatematsu M, Yamamoto M, Iwata H, et al. Induction of the glandular stomach cancers in C3H mice treated with N-mthyl-N-nitrosourea in the drinking water. Jpn J Cancer Res 1992; 84: 1258-64.
74. Hirose M, Fukushima S, Tanaka H, et al. Carcinogenicity of catechol in F344 rats and B6C3F1 mice. Carcinogenesis 1993; 14: 525-9.
75. Kogure K, Sasadaira H, Kawachi T, et al. Further studies on induction of stomach cancer in hamsters by N-methyl-N′-nitro-N-nitrosoguanidine. Br J Cancer 1974; 29: 132-42.
76. Fujimura S, Kogure K, Oboshi S, et al. Production of tumors in glandular stomach of hamsters by N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Res 1970; 30: 1444-8.
77. Sugimura T, Tanaka N, Kawachi T, et al. Production of stomach cancer in dogs by N-methyl-N′-nitro-N-nitrosoguanidine. Gann 1971; 62: 67-8.
78. Sugimura T, Kawachi T. Experimental stomach carcinogenesis. In: Lipkin M, Good RA eds. Gastrointestinal Tract Cancer. Plenum Press, New York, 1978, pp. 327-41.
79. Matsukura N, Morino K, Ohgaki H, et al. Canine gastric carcinoma as an animal model of human gastric carcinoma. Stomach Intest 1981; 16: 715-22.
80. Koyama Y, Omori K, Hirota T, et al. Leiomyosarcomas of the small intestine in dogs by N-methyl-N′-nitro-N-nitrosoguanidine. Gann 1976; 67: 241-51.
81. Kurihara M, Shirakabe H, Murakami T, et al. A new method for producing adenocarcinomas in the stomach of dogs with N-ethyl-N'-nitro-N-nitrosoguanidine. Gann 1974; 65: 163-77.
82. Szentirmay Z, Ohgaki H, Maruyama K, et al. Early gastric cancer induced by N-ethyl-N′-nitro-N-nitrosoguanidine in a cynomolgus monkey six years after initial diagnosis of the lesion. Jpn J Cancer Res 1990; 81: 6-9.
83. Sugihara H, Tsuchihashi Y, Fukada M, et al. Cell proliferation and cell loss in intramucosal signet ring cell carcinoma of canine stomachs induced by N-ethyl-N′-nitro-N-nitrosoguanidine. J Cancer Res Clin Oncol 1985; 110: 87-94.
84. Saito T, Sasaki O, Matsukuchi T, et al. Regression of polypoid carcinoma induced by N-methyl-N′-nitro-N-nitrosoguanidine in the stomach of a dog. Gann 1980; 71: 226-30.
85. Ohgaki H, Hasegawa H, Kusama K, et al. Induction of gastric carcinomas in nonhuman primates by N-ethyl-N′-nitro-N-nitrosoguanidine. J Nat Cancer Inst 1986; 77: 179-86.
86. Sharashidze L K, Beniashvili D S, Sherenesheva N I, et al. Induction of gastric cancer in monkeys by N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). Neoplasma 1989; 36: 129-33.
87. Dubois A, Fiala N, Heman-Ackah L M, et al. Natural gastric infection with Helicobacter pylori in monkeys: a model for spiral bacteria infection in humans. Gastroenterology 1994; 106: 1405-17.
88. Geboers J, Joossens J V, Kesteloot H. Epidemiology of stomach cancer. In: Joossens J V, Hill M J, Geboers J eds. Diet and Human Carcinogenesis. Elsevier, Amsterdam, 1985, pp.81-95.
89. Tuyns A J. Salt and gastrointestinal cancer. Nutr Cancer 1988; 11: 229-32.
90. Joossens J V, Geboers J. Nutrition and gastric cancer. Proc Nutr Soc 1981; 40: 37-46.
91. Takahashi M, Hasegawa R. Enhancing effects of dietary salt on both initiation and promotion stages of rat gastric carcinogenesis. In: Hayashi Y, Nagao M, Sugimura T, Takayama S, Tomatis T, et al. eds. Diet, Nutrition and Cancer. Japan Sci Sco Press, Utrecht, 1986, pp. 169-82.
92. Buiatti E, Palli D, Decarli A, et al. Italian multicentre case-control study on gastric cancer and diet. I. Frequencies of food consumption. Int J Cancer 1989; 44: 611-6.
93. Tajima K, Tominaga S. Dietary habits and gastrointestinal cancers: a comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan. Jpn J Cancer Res (Gann) 1985; 76: 705-16.
94. You W, Blot W J, Chang Y, et al. Diet and high risk of stomach cancer in Shandong, China. Cancer Res 1988; 48: 3518-23.
95. Correa P, Fontham E, Pickle L W, et al. Dietary determinants of gastric cancer in south Louisiana inhabitants. J Natl Cancer Inst 1985; 75: 645-54.
96. LaVecchia C, Negri E, Decarli A, et al. A case-control study of diet and gastric cancer in northern Italy. Int J Cancer 1987; 40: 198-205.
97. 7 Tsugane S, Akabane M, Inami T, et al. Urinary salt excretion and stomach cancer mortality among four Japanese populations. Cancer Causes and Control 1991; 2: 165-8.
98. Friedman G D, Parsonnet J. Salt intake and stomach cancer: some contrary evidence. Cancer Epid Biomarkers Prevention 1992; 1: 607-8.
99. Newberne P M, Charnley G, Adams K, et al. Gastric carcinogenesis: a model for the identification of risk factors. Cancer Letters 1987; 38: 149-63.
100. Takahashi M, Kokubo T, Furukawa F, et al. Effect of high salt diet on rat gastric carcinogenesis indiced by N-methyl-N′-nitro-N-nitrosoguanidine. Gann 1983; 74: 28-34.
101. Tatematsu M, Takahashi M, Fukushima S, et al. Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N′-nitro-N-nitrosoguanidine or 4-nitroquinoline-1-oxide. J Natl Cancer Inst 1975; 55: 101-6.
102. Furihata C, Sato Y, Hosaka M, et al. NaCl induced ornithine decarboxylase and DNA synthesis in rat stomach mucosa. Biochem Biophys Res Commum 1984; 121: 1027-32.
103. Ohgaki H, Sentirmay Z, Take M, et al. Effects of 4-week treatment with gastric carcinogens and enhancing agents on proliferation of gastric mucosa cells in rats. Cancer Letters 1989; 46: 117-22.
104. Sorbye H, Svanes C, Stangeland L, et al. Epithelial restitution and cellular proliferation after gastric mucosal damage caused by hypertonic NaCl in rats. Virch Arch A Pathol Anat 1988; 413: 445-55.
105. Sorbye H, Maartmann-Moe H, Svanes K. Gastric carcinogenesis in rats given hypertonic salt at different time before a single dose of N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Res Clin Oncol 1994; 120: 159-63.
106. Sorbye H, Kvinnsland S, Svanes K. Effect of salt-induced mucosal damage and healing on penetration of N-methyl-N′-nitro-N-nitrosoguanidine to proliferative cells in the gastric mucosa of rats. Carcinogenesis 1994; 15: 673-9.
107. Sorbye H, Guttu K, Gislason H, et al. Gastric mucosal injury and associated changes in mucosal blood flow and gastric fluid secretion caused by dimethyl sulfoxide (DMSO) in rats. Dig Dis Sci 1993; 38: 1243-50.
108. Tatematsu M, Takahashi M, Hananouchi M, et al. Protective effect of mucin on experimental gastric cancer induced by N-methyl-N′-nitro-N-nitrosoguanidine plus sodium chloride in rats. Gann 1976; 67: 223-9.
109. Watanabe H, Takahashi T, Okamoto T, et al. Effects of sodium chloride and ethanol on stomach tumorigenesis in ACI rats treated with N-methyl-N′-nitro-N-nitrosoguanidine: a quantitative morphometric approach. Jpn J Cancer Res 1992; 83: 588-93.
110. Sato T, Fukuyama T, Urata F, et al. Studies of the causation of gastric cancer. I. Bleeding in the glandular stomach of mice by feeding with highly salted foods, and a comment on salted foods in Japan. Jap Med J 1959; 1835: 25.
111. Kodama M, Kodama T, Suzuki H, et al. Effect of rice and salty rice diets on the structure of mouse stomach. Nutr Cancer 1984; 6: 135-47.
112. Fox J G, Li X, Cahill R J, et al. Hypertrophic gastrophy in Helicobacter felis infected wildtype C57B1/6 mice and p53 hemizygous transgenic mice. Gastroenterology 1996; 110: 155-66.
113. Mohammadi M, Redline R, Nedrud J, et al. Role of the host in pathogenesis of Helicobacter-associated gastritis: H felis infection of inbred and congenic mouse strains. Infec Immunity 1996; 64: 238-45.
114. DeKoster E, Buset M, Fernandes E, et al. Influence of sodium intake on gastric antrum and corpus mucosal cell proliferation status. Acta Gastroenterol Belg 1993; 56 (Suppl.): 54.
115. Fox J G. In vivo studies of emergent issues in gastric Helicobacter pathogenesis and epidemiology. In: Hunt RH, Tytgat GNJ, eds: Helicobacter pylori: Basic Mechanisms to Clinical Cure. Kluwer Academic Publishers, Lancaster, UK, 1996, pp. 11-32.
116. Fox J G, Lee A. The role of Helicobacter species in gastrointestinal tract diseases of animals. Lab Animal Sci 1997; 47: 222-55.
117. Schreiber H, Nettesheim P, Lijinsky W, et al. Induction of lung cancer in germfree, specific-pathogen-free, and infected rats by N-methyl-N′-nitro-N-nitrosoguanidine: enhancement by respiratory infection. J Natl Cancer Inst 1972; 49: 1107-14.
118. Fox J G, Chilvers T, Goodwin C S. Campylobacter mustelae, a new species resulting from the elevation of Campylobacter pylori subsp. mustelae to species status. Int J Sys Bacteriol 1989; 39: 301-3.
119. Fox J G, Cabot E B, Taylor N S, et al. Gastric colonization of Campylobacter pylori subsp. mustelae in ferrets. Infect Immun 1988; 56: 2994-6.
120. Fox J G, Lee A. Gastric helicobacter infection in animals: natural and experimental infections. In: Goodwin CS, Worsley BW eds. Biology and Clinical Practice. CRC Press, Boca Raton, FL, 1993, pp. 407-30.
121. Blanchard T G, Nedrud J G, Czinn S J. Development of a rat model of H. pylori infection and disease to study the role of H.pylori in gastric cancer incidence. Gut 1996; 39 (Suppl. 2): A76 (Abstract).
122. Lee A, O'Rourke J, DeUngria M C, et al. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997; 112: 1386-97.
123. Kleanthous H, Tibbitts T, Bakios T J, et al. In vivo selection of a highly adapted H. pylori isolate and the development of an H. pylori mouse model for studying vaccine efficacy and attenuating lesions. Gut 1995; 37 (Suppl. 1): A94 (Abstract).
124. Karita M, Li Q, Cantero D, et al. Establishment of a small animal model for human H. pylori infection using germ-free mouse. Am J Gastroenterology 1994; 89: 208-13.
125. Marchetti M, Arico B, Burroni D, et al. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267: 1655-8.
126. McColm A A, Bagshaw J, O'Malley C, et al. Development of a mouse model of gastric colonisation with Helicobacter pylori. Gut 1995; 37 (Suppl. 1): A50 (Abstract).
127. Fox J G, Correa P, Taylor N S, et al. Helicobacter mustelae associated gastritis in ferrets: an animal model of Helicobacter pylori gastritis in humans. Gastroenterology 1990; 99: 352-61.
128. Fox J G. Biology and Diseases of the Ferret. Lea & Febiger, Philadelphia, 1988.
129. Perkins S E, FoxJ G, Walsh J H. Helicobacter mustelae associated hypergastrinemia in ferrets (Mustela putorius furo). Am J Vet Res 1996; 57: 147-50.
130. Lipkin M, Bell B, Sherlock P. Cell proliferation kinetics in the gastrointestinal tract of man. II. Cell renewal in stomach, ileum, colon and rectum. Gastroenterology 1964; 45: 721-9.
131. Riecken E O, Menge H. Nutritive effects of food constituents on the structure and function of the intestine. Acta Hepatogastroenterol 1977; 24: 388-99.
132. Leblond C P, Carriere R M. The effect of growth hormone thyroxine on the mitotic rate of the intestinal mucosa of the rat. Endocrinology 1955; 56: 261-6.
133. Lipkin M, Higgins P. Biological markers of cell proliferation and differentiation in human gastrointestinal diseases. Adv Cancer Res 1988; 50: 1-24.
134. Lipkin M. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res 1988; 48: 235-45.
135. Lipkin M, Correa P, Mikol Y B, et al. Proliferative and antigenic modifications in epithelial cells in chronic atrophic gastritis. J Natl Cancer Inst 1985; 75: 613-9.
136. Moss S F, Calam J, Agarwal B, et al. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498-501.
137. Lippman S M, Lee J S, Lotan R, et al. Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst 1990; 82: 555-60.
138. Gratzner H G. A new reagent for detection of DNA replication. Science 1982; 218: 474-5.
139. Dean P N, Dolbeare F, Gratzner H, et al. Cell-cycle analysis using a monoclonal antibody to BrdU. Cell Tissue Kinet 1984; 17: 427.
140. Risio M, Lipkin M, Canelaresi G, et al. Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res 1991; 51: 1917-21.
141. Bravo R, Frank R, Blundell P A, et al. Cyclin/PCNA is the auxiliary protein of DNA polymerase-d. Nature 1987; 326: 515-20.
142. Sarraf C E, McCormick C S F, Brown G E, et al. Proliferating cell nuclear antigen immunolocalization in gastrointestinal epithelia. Digestion 1991; 50: 85-91.
143. Brenes F, Ruiz B, Correa P, et al. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 1993; 88: 1870-75.
144. Yu J, Russell R M, Salomon R N, et al. Effect of Helicobacter mustelae infection on ferret gastric epithelial cell proliferation. Carcinogenesis 1995; 16: 1927-31.
145. Fox J G, Lee A, Otto G, et al. Helicobacter felis gastritis in gnotobiotic rats: an animal model of Helicobacter pylori gastritis. Infect Immun 1991; 59: 785-91.
146. Lee A, Fox J G, Otto G, et al. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 1990; 99: 1315-23.
147. Fox J G, Blanco M, Murphy J C, et al. Local and systemic immune response in murine Helicobacter felis active chronic gastritis. Infect Immun 1993; 61: 2309-15.
148. Lee A, O'Rourke J, Dixon M, et al. Helicobacter-induced gastritis: look to the host. Acta Gastro-Enterol BeIg 1993; 56 (Suppl.).
149. Sakagami T, Shimoyama T, O'Rourke J, et al. Back to the host: severity of inflammation induced by Helicobacter felis in different strains of mice. Am J Gastroenterol 1994; 89: 1345 (Abstract 241).
150. Andrutis K A, Li X, Wang T C, et al. Gastric carcinogenesis of MNU in Helicobacter felis infected mice. Gut 1996; 39 (Suppl. 2): A79 (Abstract).
151. Enno A, O'Rourke J L, Howlett C R, et al. MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. Am J Pathol 1995; 147: 217-23.
152. Calvert R, Randerson J, Evans P, et al. Genetic adnormalities during transition from Helicobacter pylori-associated gastritis to low grade MALToma. Lancet 1995; 345: 26-7.
153. Karita M, Kouchiyama T, Okita K. et al. New small animal model for human gastric Helicobacter pylori infection: success in both nude and euthymic mice. Am J Gastroenterol 1991; 86: 1596-603.
154. Harris C C. p53 tumor suppressor gene: from the basic research laboratory to the clinic -an abridged historical perspective. Carcinogenesis 1996; 17: 1187-98.
155. Donehower L A, Harvey M, Slagle B L, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992; 356: 215-21.
156. Lee A, Hazell S L, O'Rourke J. Isolation of a spiral-shaped bacterium from the cat stomach. Infect Immun 1988; 56: 2843-50.
157. Takagi H, Jhappan C, Sharp R, et al. Hypertrophic gastrophy resembling Menetrier's disease in transgenic mice overexpressing transforming growth factor a in the stomach. J Clin Invest 1992; 90: 1161-7.
158. Harvey M, McArthur M J, Jr C A M, et al. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 1993; 5: 225-9.
159. Fox J G, Dangler C A, Whary M T, et al. Decreased histopathologic and immune responses to Helicobacter felis infection in mice carrying a truncated APC gene. Cancer Res 1997; 57: 3972-8.
160. Wang T C. Biology of gastric cancer. In: Rustgi AK ed. Gastrointestinal Cancers: Biology, Diagnosis and Therapy. Lippincott-Raven, Philadelphia, PA, 1995, pp. 243-60.
161. Ward J M, Fox J G, Anver M R, et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Nat Cancer Inst 1994; 86: 1222-7.
162. Fox J G, Dewhirst F E, Tully J G, et al. Helicobacter hepaticus sp. nov, a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 1994; 32: 1238-45.
163. Fox J G. Li X, Yan L, et al. Chronic proliferative hepatitis in A/JCr mice associated with persistent H. hepaticus infection: a model of Helicobacter induced carcinogenesis. Infect Immun 1996; 64: 1548-58.
164. Fox J G, Yan L, Shames B, et al. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun 1996; 64: 3673-81.
165. Shames B, Fox J G, Dewhirst F F, et al. Identification of widespread H. hepaticus infection in feces in commercial mouse colonies by culture and PCR assay. J Clin Microbiol 1995; 33: 2968-72.
166. Foltz C, Fox J G, Yan L, et al. Evaluation of antibiotic therapies for the eradication of Helicobacter hepaticus. Antimicrobial Agents Chemother 1995; 36: 1292-4.
167. Fox J G, Yan L, Dewhirst F E, et al. Helicobacter bilis sp. nov., a novel Helicobacter isolated from bile, livers, and intestines of aged, inbred mouse strains. J Clin Microbiol 1995; 33: 445-54.
168. Xu J K, Goodwin C S, Cooper M, et al. Intracellular vacuolization caused by the urease of Helicobacter pylori. J Infect Dis 1990; 161: 1302-4.
169. Smoot D T, Mobley H L T, Chippendale G R, et al. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun 1990; 58: 1992-4.
170. Cover T L, Puryear W, Perez-Perez G I, et al. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun 1991; 59: 1264-70.
171. Figura N, Guglielmetti P, Rossolini A. Cytotoxin production by Campylobacter pyrlori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989; 27: 225-6.
172. Taylor D N, Parsonnet J. Epidemiology and natural history of Helicobacter pylori infection. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL eds. Infections of the Gastrointestinal Tract. Raven Press, New York, 1995, pp. 565-88.
173. Telford J L, Ghiara P, Dell'Orco M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179: 1653-8.
174. Ward J M, Anver M R, Haines D C, et al. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am J Pathol 1994; 145: 959-68.
175. Sundberg J P, Fox J G, Ward J M, et al. Idiopathic focal hepatic necrosis in inbred laboratory mice. In: Jones TC, Popp JA, Mohr V eds. Digestive System, 2nd edn. Springer-Verlag, New York, 1997, pp. 213-17.
176. Fox J G, MacGregor J, Sills R, et al. Role of Helicobacter hepaticus in confounding results of a triethanolamine carcinogenesis bioassay in mice. Lab Anim Sci 1997; 47: 440 (Abstract).
177. Vecchia C L, Ferraroni M, D'Avanzo B, et al. Selected micronutrient intake and the risk of gastric cancer. Cancer Epidemiol Biomarkers Prev 1994; 5: 393-8.
178. Gonzalez C A, Riboli E, Badosa J, et al. Nutritional factors and gastric cancer in Spain. Am J Epidemiol 1994; 139: 446-73.
179. Sobala G M, Pignatelli B, Schorah C J, et al. Simultaneous determination of ascorbic acid nitrite, total nitrosocompounds and bile acids in fasting gastric juice, and gastric mucosal histology implications for gastric carcinogenesis. Carcinogenesis 1991; 12: 193-8.
180. Sobala G M, Schorah C J, Pignatelli B, et al. High gastric juice ascorbic acid concentrations in members of a gastric cancer family. Carcinogenesis 1993; 14: 291-2.
181. Chen V W, Abu-Elyazeed R R, Zavala D E, et al. Risk factors of gastric precancerous lesions in a high-risk Colombian population. II. Nitrate and nitrite. Nutr Cancer 1990; 13: 67-72.
182. Bartsch H, Ohshima H, Pignatelli B. Inhibitors of endogenous nitrosation. Mechanisms and Implications in human cancer prevention. Mutat Res 1988; 202: 307-24.
183. Diplock A T. The protective roles of antioxidant nutrients in disease prevention. Backgrounder 1992; 3: 1-12.
184. Garewal H S, Meyskens F L, Killen D, et al. Response of oral leukoplakia to B-carotene. J Clin Oncol 1990; 7: 1715-20.
185. Krinsky N I. Carotenoids and cancer in animal models. J Nutr 1989; 119: 123-6.
186. Peto R, Doll R, Buckley J D, et al. Can dietary B-carotene materially reduce human cancer rates? Nature 1981; 290: 201-8.
187. Zhang L-X, Cooney R V, Bertram J S. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/IOTI/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 1991; 12: 2109-14.
188. Olson J A. Some thoughts on the relationship between vitamin A and cancer. Adv Exp MedBiol 1986; 206: 379-98.
189. Goodman D S. Overview of current knowledge of metabolism of vitamin A and
190. Haenszel W, Correa P, Lopez A, et al. Serum micronutrient levels in relation to gastric pathology. Int J Cancer 1985; 36: 43-8.
191. Gey K G, Brubacher G B, Stahelin I B. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987; 45: 1368-77.
192. Smith A H, Waller K D. Serum B-carotene in persons with cancer and their immediate families. Am J Epidemiol 1991; 133: 661-71.
193. Bendich A. Carotenoids and immune response. J Nutr 1989; 119: 112-5.
194. Santamaria L, Bianchi A, Ravetto C, et al. Prevention of gastric cancer induced by Nmethyl-N′-nitro-nitrosoguanidine in rats fed supplemental carotenoids. J Nutr Growth Cancer 1987; 4: 175-81.
195. Jones R C, Sugie S, Braley J, et al. Dietary B-carotene in rat models of gastrointestinal cancer. J Nutr 1989; 119: 509-14.
196. Crain F D, Lotspeich F J, Krause F. Biosynthesis of retinoic acid by intestinal enzymes of the rat. J Lipid Res 1967; 8: 249-54.
197. Mathews-Roth M M. Antitumor activity of B-carotene canthaxanthin and phytoene. Oncology 1982; 39: 33-7.
198. Mathews-Roth M M, Krinsky N I. Carotenoid dose level and protection against UV-B-induced skin tumors. Photochem Photobiol 1985; 42: 35-8.
199. Gronowska-Senger A, Wolf G. Effect of dietary protein on the enzyme from rat and human intestine which converts B-carotene to retinal. J Nutr 1970; 100: 300-8.
200. Goodman D S, Blomstrand R, Werner B, et al. The intestinal absorption and metabolism of vitamin A and B-carotene in man. J Clin Invest 1966; 45: 1615-23.
201. Krinsky N I, Cornwell D G, Oncley J L. The transport of vitamin A and carotenoids in human plasma. Arch Biochem Biophys 1958; 73: 233-46.
202. Ribaya-Mercado J D, Holmgren S C, Fox J G, et al. Dietary B-carotene absorption and metabolism in ferrets and rats. J Nutr 1989; 119: 665-8.
203. Ribaya-Mercado J D, Fox J G, Rosenthal W D, et al. B-carotene, retinol, andretinyl ester concentrations in serum and selected tissues of ferrets fed B-carotene. J Nutr 1992; 122: 1898-903.
204. Wang X D, Krinsky N I, Marini R P, et al. The lymphatic and intestinal absorption of B-carotene in ferret - a useful model for human metabolism. Am J Physiol 1992; 263: 6480-6.
205. Wang X-D, Tang G-W, Fox J G, et al. Enzymatic conversion of β-carotene into β-apo-carotenals and retinoids by human, monkey, ferret, and rat tissues. Arch Biochem Biophys 1991; 285: 8-16.
206. Wang X D, Krinsky N I, Tang G, et al. Retinoic acid can be produced from excentric cleavage of B-carotene in human intestinal mucosa. Arch Biochem Biophys 1992; 293: 298-304.
207. Anderson L M. Characterization of ethanol's enhancement of tumorigenesis by N-nitroso-dimethylamine in mice. Carcinogenesis 1992; 13: 2107-11.